Cara Therapeutics Q1 loss widens but beats estimates
Cara Therapeutics Inc. (NASDAQ: CARA) reported a wider loss in the first quarter of 2019 due to higher costs and expenses. The bottom line was narrower…
Cara Therapeutics Inc. (NASDAQ: CARA) reported a wider loss in the first quarter of 2019 due to higher costs and expenses. The bottom line was narrower…
Come Thursday and Cronos Group (NASDAQ: CRON) officially kicks off another season of cannabis stock earnings. The Toronto-based marijuana firm is scheduled to report first-quarter…
SurveyMonkey, the parent company of SVMK Inc (NASDAQ: SVMK), is scheduled to report its earnings results for the first quarter of 2019 on Wednesday after…
The autonomous vehicle unit of General Motors (NYSE: GM ) received a big fillip this week after it secured a $1.15-billion funding from an investor group.…
Duke Energy Corp. (NYSE: DUK) ended the last fiscal year on a dismal note, after facing multiple challenges including the general slump in the power…
MannKind Corporation (NASDAQ: MNKD) reported a narrower loss in the first quarter of 2019 helped by higher total revenues. The bottom line was narrower than…
Array BioPharma (NASDAQ: ARRY) reported a narrower-than-expected loss in the third quarter of 2019, sending its shares up 0.5% during pre-market trading on Tuesday. The…
Mylan’s (MYL) stock plunged about 5% in the pre-market trading after the company’s revenues failed to meet estimates. However, adjusted earnings surpassed the consensus for…
Ferrari NV’s (NYSE: RACE) shares gained over 5% in the morning trade on Tuesday after the company surpassed estimates on earnings for the first quarter…
Anheuser-Busch Companies (NYSE: BUD), the manufacturer of popular beer brand Budweiser, Tuesday reported an increase in first-quarter earnings, supported by strong sales in key markets…